The Business Research Company’s “Anti-Infective Drugs Market” under Pharmaceuticals category covers market characteristics, key players, market size and trends from 2019 to 2022.
The global anti-infective drugs market is is expected to grow at a CAGR of around 6% to nearly $116 billion by 2022. Growth in the historic period resulted from the rise in incidence rate of infectious diseases, aging population and growth in emerging markets.
The anti-infective drugs market consists of sales of branded and generic anti-infective drugs and related services by entities (organizations, sole traders and partnerships) that manufacture branded or generic anti-infective drugs to treat microbial infections.
Request a Sample Report At: https://www.thebusinessresearchcompany.com/sample.aspx?id=2348&type=smp
The anti-infective drugs market is expected to benefit from the latest developments in drug discovery procedures such as stem cells and organ-on-chip (OOC) technologies. OOCs are micro-engineered biometric systems that simulate the activities, mechanics and physiological responses of organ systems. Drug trial processes such as target identification, validation, and screening are being executed through OOC and stem cell technologies.
The global anti-infective drugs market is facing supply shortages of anti-biotic drugs, especially antibiotics, due to the presence of few antibiotics manufacturers in the market. This can be attributed to low profits margins in the industry and exit strategies adopted by the market players. This has given rise to heavy reliance on a few manufacturers, leading to shortages of antibiotics supply, thus restraining the market’s growth.
Purchase Report At: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2348
North America was the largest market for anti-infective drugs, accounting for a 47.7% of the global market in 2018. It was followed by Western Europe, Asia-Pacific and then the other regions. Going forward, Africa and Middle East will be the fastest growing regions in this market.
Some of the major players involved in the anti-infective drugs market are Gilead Sciences, GlaxoSmithKline plc, Merck & Co, Teva Pharmaceutical Industries Ltd, Johnson & Johnson, Boehringer Ingelheim GmbH, Pfizer, Mylan N.V., Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd, Shanghai Pharmaceuticals, Shanghai Fosun Pharmaceutical, Cipla, Dr. Reddy’s Laboratories Ltd., Sun Pharma, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, Roche, Novartis, Sanofi, AstraZeneca, Novo Nordisk, Bayer, Sotex, Microgen, Adcock Ingram and Aspen.
View complete Report: https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market
About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
This post was originally published on The Market Plan